ES2126579T3 - Comprimidos de dispersion solida que contienen derivados de 1,4-dihidropiridina y procedimiento para su preparacion. - Google Patents

Comprimidos de dispersion solida que contienen derivados de 1,4-dihidropiridina y procedimiento para su preparacion.

Info

Publication number
ES2126579T3
ES2126579T3 ES92109459T ES92109459T ES2126579T3 ES 2126579 T3 ES2126579 T3 ES 2126579T3 ES 92109459 T ES92109459 T ES 92109459T ES 92109459 T ES92109459 T ES 92109459T ES 2126579 T3 ES2126579 T3 ES 2126579T3
Authority
ES
Spain
Prior art keywords
solid dispersion
substituted
group
preparation
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92109459T
Other languages
English (en)
Inventor
Daiichi B- Watanabe
Hiroko Mimachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Fujirebio Inc
Original Assignee
Ajinomoto Co Inc
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc, Fujirebio Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of ES2126579T3 publication Critical patent/ES2126579T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION ESTA RELACIONADA CON UN COMPRIMIDO FARMACEUTICO DE DISPERSION DE SOLIDOS QUE COMPRENDE UN MATERIAL DE DISPERSION DE SOLIDOS (A) QUE COMPRENDE UN DERIVADO DE 1,4DIHIDROPIRIDINA COMO AGENTE ACTIVO FARMACEUTICO REPRESENTADO POR LA FORMULA GENERAL [I]: EN DONDE AR ES UN ARILO SUBSTITUIDO O UN GRUPO BENZOFURAZANILO, R1 ES UN GRUPO ALQUILO SUBSTITUIDO O NO SUBSTITUIDO, R2 ES UN GRUPO ALQUILO O ALQUENILO SUBSTITUIDO O NO SUBSTITUIDO O UN GRUPO PIPERIDILO SUBSTITUIDO, R3 Y R4 CADA UNO INDEPENDIENTEMENTE REPRESENTA UN GRUPO ALQUILO SUBSTITUIDO O NO SUBSTITUIDO, Y LOS SUBSTITUYENTES R1OCO CION 5 SE PUEDEN SUBSTITUIR POR UN GRUPO DIALQUILFOSFONOATO O DIOXIFOSFORILO DE ALQUILENO, O UNA SAL DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLE DEL MISMO Y HIDROXIPROPIL CELULOSA; Y UN MATERIAL DE DISPERSION DE SOLIDOS (B) QUE COMPRENDE DICHO DERIVADO DE 1,4-DIHIDROPIRIDINA O SU SAL DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLE E HIDROXIPROPIL METIL CELULOSA FTALATO. LA PRESENTE INVENCION TAMBIEN ESTA RELACIONADA CON UN PROCESO PARA LA PREPARACION DE LOS COMPRIMIDOS DE DISPERSION DE SOLIDOS ANTERIORES
ES92109459T 1991-06-05 1992-06-04 Comprimidos de dispersion solida que contienen derivados de 1,4-dihidropiridina y procedimiento para su preparacion. Expired - Lifetime ES2126579T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03134344A JP3110794B2 (ja) 1991-06-05 1991-06-05 １，４−ジヒドロピリジン誘導体を含有する製剤

Publications (1)

Publication Number Publication Date
ES2126579T3 true ES2126579T3 (es) 1999-04-01

Family

ID=15126164

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92109459T Expired - Lifetime ES2126579T3 (es) 1991-06-05 1992-06-04 Comprimidos de dispersion solida que contienen derivados de 1,4-dihidropiridina y procedimiento para su preparacion.

Country Status (6)

Country Link
EP (1) EP0521310B1 (es)
JP (1) JP3110794B2 (es)
KR (1) KR100209201B1 (es)
AT (1) ATE175874T1 (es)
DK (1) DK0521310T3 (es)
ES (1) ES2126579T3 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9300504A (en) * 1993-09-28 1995-04-30 Krka Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
CA2346350C (en) 1998-10-05 2008-01-08 Eisai Co., Ltd. Intraoral quickly disintegrating tablets
EP2415462A1 (en) 1999-12-23 2012-02-08 Mayne Pharma International Pty Ltd. Improved pharmaceutical compositions for poorly soluble drugs
ES2287110T3 (es) * 2000-04-11 2007-12-16 Sankyo Company, Limited Composicion farmaceutica estabilizada que contiene un bloqueador de calcio consistente en azelnidipina.
DE10058772A1 (de) * 2000-11-27 2002-06-06 Falk Pharma Gmbh Verfahren zur Herstellung leicht löslicher Arzneimittelformulierungen und entsprechende Formulierungen
KR20040011248A (ko) * 2002-07-30 2004-02-05 환인제약 주식회사 암로디핀의 고체분산체와 그 제조방법 및 그를 포함하는약학적 조성물
WO2007060540A1 (en) * 2005-11-25 2007-05-31 Aurobindo Pharma Limited Stable dosage forms of an antidepressant
KR101434316B1 (ko) * 2006-04-19 2014-08-28 아지노모토 가부시키가이샤 고체 분산체의 필름 코팅방법
KR101422052B1 (ko) * 2006-04-19 2014-07-23 아지노모토 가부시키가이샤 할선 정제
JP5320759B2 (ja) * 2006-04-19 2013-10-23 味の素株式会社 割線錠剤
WO2008120724A1 (ja) * 2007-03-30 2008-10-09 Ajinomoto Co., Inc. 固体分散体製剤
CN102415998A (zh) * 2010-09-28 2012-04-18 扬子江药业集团北京海燕药业有限公司 盐酸马尼地平固体分散体及其制备方法
BR112014031706A8 (pt) 2012-06-21 2021-10-19 Mayne Pharma Int Pty Ltd Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol
WO2014058046A1 (ja) * 2012-10-12 2014-04-17 味の素株式会社 カルシウム拮抗薬／アンジオテンシンｉｉ受容体拮抗薬含有医薬製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS58109411A (ja) * 1981-12-23 1983-06-29 Shionogi & Co Ltd ニフエジピン固型製剤組成物
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
US5028433A (en) * 1988-11-30 1991-07-02 Banyu Pharmaceutical Co., Ltd. Readily absorbable drug formulation of NB-818

Also Published As

Publication number Publication date
EP0521310A3 (en) 1994-10-05
DK0521310T3 (da) 1999-09-13
ATE175874T1 (de) 1999-02-15
JP3110794B2 (ja) 2000-11-20
JPH04360833A (ja) 1992-12-14
EP0521310B1 (en) 1999-01-20
EP0521310A2 (en) 1993-01-07
KR100209201B1 (ko) 1999-07-15

Similar Documents

Publication Publication Date Title
ES2126579T3 (es) Comprimidos de dispersion solida que contienen derivados de 1,4-dihidropiridina y procedimiento para su preparacion.
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
ES2061848T3 (es) Compuestos triciclos, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
NO883229L (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
DK297483D0 (da) Fremgangsmade til fremstilling af derivater af 9-(2-hydroxyethoxymethyl) guanin
NO156690C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanderivater.
ES2061462T3 (es) Compuestos cefemo, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
SE8405754L (sv) 7-karboximetoxi-furo-(3,4-c)-pyridinderivat, framstellning derav och terapeutiska kompositioner innehallande dem
MX9301197A (es) Derivados de indol.
HUT67661A (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
ATE10368T1 (de) Uracilderivate, verfahren zu ihrer herstellung und eine diese enthaltende pharmazeutische zubereitung.
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
FR2681324B1 (fr) Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant.
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
ES2153019T3 (es) Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE3429T1 (de) Paromomycin-derivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammenzetzung.
ES2093246T3 (es) Compuestos de benzazepina terapeuticos.
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
SE7702232L (sv) Forfarande for framstellning av substituerade 8-azapurinderivat
ES471993A1 (es) Procedimiento de preparacion de nuevos derivados de alcaloi-des pentaciclicos
ES2053652T3 (es) N-(alquilideno sustituido)-1,2,3,4,-tetrahidro-9-acridinaminas, un procedimiento para su preparacion y su uso como medicamentos.
ES2059471T3 (es) Un procedimiento para preparar un derivado de rodamina.
HUT44781A (en) Process for production of 2-benzimidasolile-alkyl-tioderivatives and medical preparatives containing them as active substance
AR008245A1 (es) Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 521310

Country of ref document: ES